We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis.
- Authors
Song, Parkyong; Hwang, Ji Sun; Park, Hyean Cheal; Kim, Keun Ki; Son, Hong-Joo; Kim, Yu-Jin; Lee, Kwang Min; Yang, Siyoung
- Abstract
Type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) are common chronic diseases that frequently co-exist. The link between OA and T2DM is attributed to common risk factors, including age and obesity. Several reports suggest that hyperglycemia and accumulated advanced glycosylation end-products might regulate cartilage homeostasis and contribute to the development and progression of OA. Metformin is used widely as the first-line treatment for T2DM. The drug acts by regulating glucose levels and improving insulin sensitivity. The anti-diabetic effects of metformin are mediated mainly via activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), which is an energy sensing enzyme activated directly by an increase in the AMP/ATP ratio under conditions of metabolic stress. Dysregulation of AMPK is strongly associated with development of T2DM and metabolic syndrome. In this review, we discuss common risk factors, the association between OA and T2DM, and the role of AMPK. We also address the adaptive use of metformin, a known AMPK activator, as a new drug for treatment of patients with OA and T2DM.
- Subjects
TYPE 2 diabetes; INSULIN sensitivity; METFORMIN; HYPERGLYCEMIA; ADENOSINE monophosphate; PROTEIN kinases
- Publication
Pharmaceuticals (14248247), 2021, Vol 14, Issue 2, p152
- ISSN
1424-8247
- Publication type
Article
- DOI
10.3390/ph14020152